Rochester, NY 7/9/2009 10:25:39 PM
News / Finance

WhisperfromWallStreet.com Stock Report - BSX - Boston Scientific to Webcast Conference Call Discussing Second Quarter Financial Results

Boston Scientific Corporation,BSX

WhisperfromWallStreet.com Stock Report - BSX - Boston Scientific to Webcast Conference Call Discussing Second Quarter Financial Results

Boston Scientific Corporation,BSX

Last Trade:          9.64
Day's Range:      9.63 - 9.94
52wk Range:     5.41 - 14.20
Volume:               3,861,618

Boston Scientific Corporation (NYSE: BSX - News) will webcast its conference call discussing financial results for the second quarter ended June 30, 2009 on Tuesday, July 21, at 8:00 a.m. ET.

9.60 Down 0.27 (2.74%) 11:15AM ET

ABOUT THE COMPANY


Boston Scientific Corporation operates as a developer, manufacturer, and marketer of medical devices used in various interventional medical specialties worldwide. Its products help physicians and other medical professionals improve the patients' quality of life by providing alternatives to surgery. The company's cardiovascular group consists of drug-eluting and bare-metal stents, coronary revascularization products, Intraluminal ultrasound imaging catheters and systems, Embolic protection system, peripheral and neurovascular interventions, electrophysiology devices, and cardiac rhythm management devices.

---

There are hundreds of stocks that rise and fall each day, our expertise is understanding which have the best opportunity for rapid growth.  Our newsletter has sent out over 40 alerts this year with an average price gain of 80%.  If you like to be alerted to the stocks that meets our criteria.  Please join us for free to track our results.

You can sign up now for free stock alerts at WhisperfromWallStreet.com

---

Plese read the
COMPLETE DISCLAIMER posted on our website.

IMPORTANT NOTE: This is not a solicitation to buy or sell any securities. Neither WhisperfromWallStreet.com, nor any of its affiliates are registered investment advisors or a broker dealer. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.